APA
Klintman M., Nilsson F., Bendahl P., Fernö M., Liljegren G., Emdin S. & Malmström P. (20140514). A prospective, multicenter validation study of a prognostic index composed of S-phase fraction, progesterone receptor status, and tumour size predicts survival in node-negative breast cancer patients: NNBC, the node-negative breast cancer trial. : Annals of oncology : official journal of the European Society for Medical Oncology.
Chicago
Klintman M, Nilsson F, Bendahl P-O, Fernö M, Liljegren G, Emdin S and Malmström P. 20140514. A prospective, multicenter validation study of a prognostic index composed of S-phase fraction, progesterone receptor status, and tumour size predicts survival in node-negative breast cancer patients: NNBC, the node-negative breast cancer trial. : Annals of oncology : official journal of the European Society for Medical Oncology.
Harvard
Klintman M., Nilsson F., Bendahl P., Fernö M., Liljegren G., Emdin S. and Malmström P. (20140514). A prospective, multicenter validation study of a prognostic index composed of S-phase fraction, progesterone receptor status, and tumour size predicts survival in node-negative breast cancer patients: NNBC, the node-negative breast cancer trial. : Annals of oncology : official journal of the European Society for Medical Oncology.
MLA
Klintman M, Nilsson F, Bendahl P-O, Fernö M, Liljegren G, Emdin S and Malmström P. A prospective, multicenter validation study of a prognostic index composed of S-phase fraction, progesterone receptor status, and tumour size predicts survival in node-negative breast cancer patients: NNBC, the node-negative breast cancer trial. : Annals of oncology : official journal of the European Society for Medical Oncology. 20140514.